Glutamate release promotes growth of malignant gliomas

Nature Medicine

Volumn 7, Issue 9, 2001, Pages 1010-1015

  Takano, Takahiro ^a   Lin, Jane H C ^a   Arcuino, Gregory ^a   Gao, Qun ^a   Yang, Jay ^b   Nedergaard, Maiken ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ARTICLE; BIOLUMINESCENCE; BRAIN TUMOR; CANCER GROWTH; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GLIOBLASTOMA; GLIOMA CELL; HEAD INJURY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NEUROTOXICITY; PRIORITY JOURNAL; STROKE;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GLIOMA; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; LUMINESCENT MEASUREMENTS; MALE; MEMANTINE; NEOPLASM TRANSPLANTATION; NEURONS; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 0034800265     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0901-1010     Document Type: Article

References (44)

1. Gene therapy of experimental brain tumors using neural progenitor cells
2. Epilepsy and brain tumors: Implications for treatment
3. A review of 2, 413 tumours operated over a 30-year period
4. Glioma cells release excitotoxic concentrations of glutamate
5. Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange
6. Extracellular glutamate and other metabolites in and around RG2 rat glioma: An intracerebral microdialysis study
7. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: Implication in Alzheimer's disease
8. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats
9. Stimulation of tumour angiogenesis by proximal wounds: Spatial and temporal analysis by MRI
10. Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter
11. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma
12. Astrocytic gap junctions remain open during ischemic conditions
13. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells
14. Localization of neuronal and glial glutamate transporters
15. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin
16. Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange
17. Direct gap junction communication between malignant glioma cells and astrocytes
18. A bioluminescence method for the measurement of L-glutamate: Applications to the study of changes in the release of L-glutamate from lateral geniculate nucleus and superior colliculus after visual cortex ablation in rats
19. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes
20. Gap-junction-mediated propagation and amplification of cell injury
21. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas
22. Evaluation of memantine for neuroprotection in dementia
23. Memantine is a clinically well tolerated Nmethyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data
24. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - Preclinical studies
25. Trauma and the localization of tumor cells
26. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor
27. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
28. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
29. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions
30. Neuronal regulation of glutamate transporter subtype expression in astrocytes
31. The course of seizure disorders in patients with malignant gliomas
32. Epilepsy and gliomas: Incidence and treatment in 119 patients
33. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
34. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology
35. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
36. The changing landscape of ischaemic brain injury mechanisms
37. Ischemic cell death in brain neurons
38. β-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis
39. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER)
40. The low-affinity, use-dependent NMDA receptor antagonist ARR 15896AR. An update of progress in stroke
41. Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells
42. Astrocyte-mediated potentiation of inhibitory synaptic transmission